Ubs Group Ag Xencor Inc Transaction History
Ubs Group Ag
- $611 Billion
- Q3 2025
A detailed history of Ubs Group Ag transactions in Xencor Inc stock. As of the latest transaction made, Ubs Group Ag holds 1,175,267 shares of XNCR stock, worth $17.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,175,267
Previous 776,196
51.41%
Holding current value
$17.5 Million
Previous $6.1 Million
125.98%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding XNCR
# of Institutions
216Shares Held
81.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$166 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.7MShares$159 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.1MShares$106 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.22MShares$92.9 Million0.98% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$91.7 Million5.41% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $891M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...